Aug 3 (Reuters) - Eli Lilly and Co:

* ELI LILLY SAYS INTENDS TO MAKE BEBTELOVIMAB COMMERCIALLY AVAILABLE FOR PURCHASE BY U.S. STATES/TERRITORIES, THROUGH SOLE DISTRIBUTOR FROM AUG. 15 Source text Further company coverage: